Swiss Medical Weekly

Journal Abbreviation: SWISS MED WEEKLY
ISSN: 1424-7860
eISSN: 1424-3997
Publisher: Swiss Medical Publishers Ltd

Publications (12)

close-button

Types of publications

Journal article
Unpublished / Preprint

Publication year

From
To

Abstract

Cost-effectiveness analysis of surgical lung volume reduction compared with endobronchial valve treatment in patients with severe emphysema (2022) Franzen D, Bodmer C, Ehrenbaum S, Steinack C, Opitz I, Docter K, Schöffski O Journal article A large-scale MicroRNA functional high-throughput screening identifies members of the MiR-515 family as potent inducers of human IPSC-cardiomyocyte proliferation (2022) Gong Y, Renikunta H, Lazarow K, Giral H, Kratzer A, Opitz L, Haghikia A, et al. Conference contribution The G protein-coupled receptor MRGX4 is a novel receptor for bile salts expressed on sensory neurons (2021) Wolf K, Kühn H, Leibl V, Gebhardt L, Glaudo M, Reeh P, Fischer MJM, et al. Conference contribution Therapy adaption by dose titration of obeticholic acid in a 57-year-old female patient with PBC and advanced liver fibrosis (2021) Vetter M, Dietrich P, Kremer A Conference contribution The burden of systemic sclerosis in Switzerland - the Swiss systemic sclerosis EUSTAR cohort (2021) Hernández J, Jordan S, Dobrota R, Iudici M, Hasler P, Ribi C, Villiger P, et al. Journal article KATHERINE: Trastuzumab emtansine vs trastuzumab as adjuvant therapy in patients with HER2-positive early breast cancer (2019) Mamounas EP, Geyer CE, Huang CS, Mano MS, Loibl S, Untch M, Wolmark N, et al. Conference contribution Load-induced changes in articular cartilage biomarkers before and after high tibial osteotomy in patients with medial knee osteoarthritis (2019) Mundermann A, Liphardt AM, Egloff C, Pagenstert G, Nuesch C Conference contribution Racial differences in SSc disease presentation: a European scleroderma trials and research group (EUSTAR) study (2018) Jaeger VK, Siegert E, Hachulla E, Airo P, Valentini G, Matucci-Cerinic M, Scorza R, et al. Conference contribution Beta-6-Integrin serves as a novel tumor marker and therapeutic target for colorectal carcinoma (2017) Bengs S, Becker E, Spalinger MR, Raselli T, Kasper S, Lang S, Atrott K, et al. Conference contribution A large cohort of patients with hepatocellular carcinoma in a single European centre: aetiology and prognosis now and in a historical cohort (2014) Ganslmayer M, Hagel A, Dauth W, Zopf S, Strobel D, Mueller V, Uder M, et al. Journal article